Discover Insights on Our Deep Tech Commercialisation Blog

Explore when continuous flow chemistry creates value in active pharmaceutical ingredient manufacturing, and when solvent recovery, solubility and process economics favour batch or hybrid manufacturing.

The global biopharmaceutical industry is transforming healthcare at an unprecedented pace. From monoclonal antibodies and biosimilars to mRNA vaccines, gene therapy and personalised medicine, biologics are changing how diseases are prevented, diagnosed and treated. As governments, investors, manufacturers and research organisations seek to strengthen their life sciences sectors, one question has become increasingly important

At Maravion, we are committed to advancing health equity and regional manufacturing capacity in Southern Africa. Over the past several years, we’ve been proud to contribute our expertise to critical studies shaping the future of the pharmaceutical sector in the SADC region, particularly in antiretroviral (ARV) production and the scaling of dolutegravir (DTG), a cornerstone drug in the fight against HIV. A Regional Vision: Strengthening SADC's Pharmaceutical Ecosystem In 2020